Chlorthalidone is a synthetic thiazide-like diuretic medication used to treat hypertension and edema. Its primary therapeutic role is to reduce blood pressure and fluid overload by promoting sodium and water excretion. The drug acts by inhibiting the na-cl cotransporter in the early distal convoluted tubule of the kidney. This inhibition increases urinary output of sodium and chloride, which leads to a decrease in circulating blood volume. The resulting reduction in plasma volume lowers cardiac output and subsequently decreases arterial pressure. The sustained antihypertensive effect is achieved through both volume reduction and direct vasodilatory actions on peripheral vessels. Together these actions provide effective control of high blood pressure and relief of excessive fluid accumulation.

Chlorthalidone is a thiazide-like diuretic that acts primarily on the distal convoluted tubule of the kidney. It inhibits sodium and chloride reabsorption, leading to increased urinary excretion of water and electrolytes. By reducing plasma volume, it lowers arterial pressure and helps maintain long-term blood pressure control. The medication also promotes potassium loss, which can affect electrolyte balance and may require monitoring. Its pharmacokinetic profile includes a long half-life, providing sustained diuretic effect after oral administration. The primary therapeutic purpose of Chlorthalidone is to treat hypertension and to manage fluid overload associated with conditions such as heart failure.

Chlorthalidone may increase the frequency of urination as the body eliminates excess fluid. It can cause dizziness or lightheadedness especially when standing up quickly. Some users experience low potassium levels which may lead to muscle weakness. Elevated uric acid can raise the risk of gout attacks in susceptible individuals. The drug may raise blood sugar levels slightly in certain patients. Dehydration can occur if fluid intake is insufficient. Mild skin rash may develop in a small number of cases.

Chlorthalidone may cause increased urine output. It can lead to low potassium levels in the blood. Some people experience dizziness or light-headedness when standing up quickly. Dehydration and low sodium can sometimes occur if fluid intake is insufficient. Muscle cramps or weakness may develop due to electrolyte shifts. The medication can raise blood glucose levels in rare cases. It may increase uric acid levels which can affect gout symptoms. Fatigue or mild low mood is occasionally reported.